Book an Appoinment

THE BLOG

HRT and GLP-1: A Combined Approach to Weight Loss in Menopause

weight loss & metabolic health Jul 01, 2026
woman jogging outdoors energised after combining HRT and GLP-1 for weight loss in menopause

Combining HRT and GLP-1 medications is providing new options for women navigating weight changes during perimenopause and menopause. For too long, many women have been told that weight gain at this stage of life is simply inevitable, when in reality, hormonal and metabolic changes can often be better understood and supported with the right approach.

 

Why Women Deserve More Than One Tool

For decades, women in perimenopause and menopause have been told that weight gain is inevitable. Hormone replacement therapy (HRT) has helped many women manage symptoms such as hot flushes, sleep disturbances and mood changes, but weight concerns often remain. Meanwhile, GLP-1 receptor agonists, including semaglutide and tirzepatide, have attracted attention for their role in supporting weight loss and metabolic health.

A growing body of research, including a 2024 study, suggests that when used together, HRT and GLP-1 medications may provide additional benefits for weight management and metabolic health compared with either therapy alone.

This highlights the importance of taking a more integrated approach to care, one that considers both hormonal health and metabolic function.

 

What Is HRT?

Hormone replacement therapy (HRT) helps replace declining hormones such as oestrogen, progesterone and, in some cases, testosterone. For many women, this may:

  • Improve sleep, mood and mental clarity
  • Reduce hot flushes and night sweats
  • Support bone density and muscle preservation
  • Improve vaginal and sexual health
  • Enhance overall quality of life

However, when it comes to weight management, HRT has its limitations. While balanced hormones can help create a more supportive environment for metabolic health, HRT alone is not typically associated with significant fat loss.

 

What Are GLP-1 Medications?

GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), work by mimicking a hormone your gut naturally produces. In practice, this means they can help by:

  • Reducing appetite and cravings
  • Slowing digestion so you feel fuller for longer
  • Improving blood sugar control
  • Lowering systemic inflammation

Together, these effects make GLP-1s a powerful tool for supporting weight management and metabolic health.

 

Why Combining HRT and GLP-1 Improves Weight Loss in Menopause

A new study highlights something really encouraging: women in perimenopause lost more weight when using both HRT and GLP-1 therapy together, compared to GLP-1 medication alone.

Here's why this combination makes so much sense:

  • HRT addresses the hormonal backdrop. Low oestrogen contributes to insulin resistance, belly fat, and muscle loss, so restoring balance gives your body a better foundation to work from.
  • GLP-1s address appetite and metabolism. They help curb cravings, balance blood sugar, and lower inflammation.
  • Together, they create a more complete approach. HRT sets the stage, and GLP-1 therapy helps accelerate the results.

You can think of it as supporting both hormonal health and metabolic health at the same time. While HRT helps address the hormonal changes that occur during perimenopause, GLP-1 medications help support appetite regulation and metabolic function.

 

Real-World Benefits for Women in Midlife

When used under appropriate medical supervision, combining HRT and GLP-1 therapy may offer several potential benefits:

• Greater improvements in weight management

• Improved energy levels and sleep quality

• Better body composition, including support for maintaining lean muscle mass

• Additional support for women who have experienced weight loss plateaus

• A more comprehensive approach that addresses both hormonal and metabolic health

 

Is It Right for You?

Not every woman is a candidate for HRT or GLP-1 therapy, and appropriate assessment and safety monitoring are essential. However, for some women in perimenopause and menopause, using these therapies together may provide additional support for both metabolic health and weight management.

If you've experienced limited progress with weight-loss medications, or you're navigating hormonal changes and wondering about your options, it's worth having a conversation with a clinician who understands both hormonal and metabolic health.

 

You Deserve All the Resources

Women's health doesn't have to be about choosing between hormone therapy and modern metabolic treatments. For some women, the most effective approach may involve addressing both hormonal and metabolic health together.

HRT can help support the hormonal changes that occur during perimenopause and menopause, while GLP-1 medications may assist with appetite regulation, metabolic health and weight management. When used appropriately and tailored to an individual's needs, these therapies may complement each other and provide additional support during this stage of life.

If you're navigating hormonal changes, struggling with weight management, or wondering whether these therapies may be right for you, we're here to help.

Book a consultation to discuss your options with our team.